default author photo

Miguel Andújar-Sánchez

Complejo Hospitalario Universitario Insular-Materno Infantil

SCHOLARLY PAPERS

2

DOWNLOADS

110

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Loss of Nuclear DNA Ligase III Reverts PARP Inhibitor Resistance in BRCA1-Deficient Cells by Increasing DNA Replication Stress

Number of pages: 69 Posted: 20 Oct 2020
Mariana Paes Dias, Vivek Tripathi, Ingrid van der Heijden, Ke Cong, Eleni-Maria Manolika, Panagiotis Galanos, Ewa Gogola, Stefano Annunziato, Cor Lieftink, Miguel Andújar-Sánchez, Marieke van de Ven, Sanjiban Chakrabarty, Roderick L. Beijersbergen, Jirina Bartkova, Sven Rottenberg, Sharon Cantor, Jiri Bartek, Arnab Ray Chaudhuri and Jos Jonkers
Netherlands Cancer Institute - Division of Molecular Pathology, Erasmus Medical Center - Department of Molecular Genetics, Netherlands Cancer Institute - Division of Molecular Pathology, University of Massachusetts Worcester - Department of Molecular, Cell and Cancer Biology, Erasmus Medical Center - Department of Molecular Genetics, Danish Cancer Society Research Centre - Genome Integrity Unit, Netherlands Cancer Institute - Division of Molecular Pathology, Netherlands Cancer Institute - Division of Molecular Pathology, Netherlands Cancer Institute - Division of Molecular Carcinogenesis, Complejo Hospitalario Universitario Insular-Materno Infantil, Netherlands Cancer Institute - Mouse Clinic for Cancer and Aging (MCCA), Manipal Academy of Higher Education (MAHE) - Department of Cell and Molecular Biology, Netherlands Cancer Institute - Division of Molecular Carcinogenesis, Danish Cancer Society Research Centre - Genome Integrity Unit, Netherlands Cancer Institute - Division of Molecular Pathology, University of Massachusetts Worcester - Department of Molecular, Cell and Cancer Biology, Danish Cancer Society Research Centre - Genome Integrity Unit, Erasmus Medical Center - Department of Molecular Genetics and Netherlands Cancer Institute - Division of Molecular Pathology
Downloads 57 (1,000,027)

Abstract:

Loading...

PARP inhibitor, DNA Ligase III, BRCA1, drug resistance, replication stress, ssDNA

2.

Hpv Self-Sampling Among Cervical Cancer Screening Users in Spain: A Randomized Clinical Trial of On-Site Training to Increase the Acceptability

Number of pages: 24 Posted: 03 Feb 2023
Raquel Ibáñez, Esther Roura, Amelia Acera, Miguel Andújar-Sánchez, Miquel Pavon, Laia Bruni and Silvia de Sanjose
Hospital Duran i Reynals (ICO) - Catalan Institute of Oncology, Hospital Duran i Reynals (ICO) - Catalan Institute of Oncology, Institut Català de la Salut, Complejo Hospitalario Universitario Insular-Materno Infantil, Gran Via de l'Hospitale, Hospital Duran i Reynals (ICO) - Catalan Institute of Oncology and National Institutes of Health, ISGlobal
Downloads 53 (1,041,696)

Abstract:

Loading...

HPV, self-sampling, acceptability, randomized clinical trial, on-site, training, Spain, cervical cancer, Screening, regular attenders